Your browser doesn't support javascript.
loading
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas.
Kim, Randie H; Nomikou, Sofia; Coudray, Nicolas; Jour, George; Dawood, Zarmeena; Hong, Runyu; Esteva, Eduardo; Sakellaropoulos, Theodore; Donnelly, Douglas; Moran, Una; Hatzimemos, Aristides; Weber, Jeffrey S; Razavian, Narges; Aifantis, Iannis; Fenyo, David; Snuderl, Matija; Shapiro, Richard; Berman, Russell S; Osman, Iman; Tsirigos, Aristotelis.
Afiliación
  • Kim RH; Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Nomikou S; Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA; Institute for Systems Genetics, Grossman School of Medicine, New York University, New York, New York, USA.
  • Coudray N; Applied Bioinformatics Laboratories, Grossman School of Medicine, New York University, New York, New York, USA; Department of Cell Biology, Skirball Institute of Biomolecular Medicine, Grossman School of Medicine, New York University, New York, New York, USA.
  • Jour G; Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA; Department of Pathology, Grossman School of Medicine, New
  • Dawood Z; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Hong R; Institute for Systems Genetics, Grossman School of Medicine, New York University, New York, New York, USA.
  • Esteva E; Department of Biomedical Engineering, Tandon School of Engineering, New York University, New York, New York, USA.
  • Sakellaropoulos T; Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA; Laura and Isaac Perlmutter Cancer Center, Grossman School of Medicine, New York University, New York, New York, USA.
  • Donnelly D; Laura and Isaac Perlmutter Cancer Center, Grossman School of Medicine, New York University, New York, New York, USA.
  • Moran U; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Hatzimemos A; Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA.
  • Weber JS; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA; Laura and Isaac Perlmutter Cancer Center, Grossman School of Medicine, New York University, New York, New York, USA.
  • Razavian N; Deparmtent of Radiology, Grossman School of Medicine, New York University, New York, New York, USA; Department of Population Health, Grossman School of Medicine, New York University, New York, New York, USA.
  • Aifantis I; Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA; Laura and Isaac Perlmutter Cancer Center, Grossman School of Medicine, New York University, New York, New York, USA.
  • Fenyo D; Institute for Systems Genetics, Grossman School of Medicine, New York University, New York, New York, USA; Department of Biochemistry and Molecular Pharmacology, Grossman School of Medicine, New York University, New York, New York, USA.
  • Snuderl M; Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA.
  • Shapiro R; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA; Department of Surgery, Grossman School of Medicine, New York University, New York, New York, USA.
  • Berman RS; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA; Department of Surgery, Grossman School of Medicine, New York University, New York, New York, USA.
  • Osman I; Ronald O. Perelman Department of Dermatology, Grossman School of Medicine, New York University, New York, New York, USA; Interdisciplinary Melanoma Cooperative Group, Grossman School of Medicine, New York University, New York, New York, USA.
  • Tsirigos A; Department of Pathology, Grossman School of Medicine, New York University, New York, New York, USA; Applied Bioinformatics Laboratories, Grossman School of Medicine, New York University, New York, New York, USA. Electronic address: Aristotelis.Tsirigos@nyulangone.org.
J Invest Dermatol ; 142(6): 1650-1658.e6, 2022 06.
Article en En | MEDLINE | ID: mdl-34757067
ABSTRACT
Image-based analysis as a method for mutation detection can be advantageous in settings when tumor tissue is limited or unavailable for direct testing. In this study, we utilize two distinct and complementary machine-learning methods of analyzing whole-slide images for predicting mutated BRAF. In the first method, whole-slide images of melanomas from 256 patients were used to train a deep convolutional neural network to develop a fully automated model that first selects for tumor-rich areas (area under the curve = 0.96) and then predicts for mutated BRAF (area under the curve = 0.71). Saliency mapping was performed and revealed that pixels corresponding to nuclei were the most relevant to network learning. In the second method, whole-slide images were analyzed using a pathomics pipeline that first annotates nuclei and then quantifies nuclear features, showing that mutated BRAF nuclei were significantly larger and rounder than BRAF‒wild-type nuclei. Finally, we developed a model that combines clinical information, deep learning, and pathomics that improves the predictive performance for mutated BRAF to an area under the curve of 0.89. Not only does this provide additional insights on how BRAF mutations affect tumor structural characteristics, but machine learning‒based analysis of whole-slide images also has the potential to be integrated into higher-order models for understanding tumor biology.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aprendizaje Profundo / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aprendizaje Profundo / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos